Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Hester Biosciences Limited (NSE: HESTERBIO), ISIN INE782E01017 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
HESTERBIO last traded at ₹2365.10 (-0.27%), with a 52-week range of ₹1239.30 to ₹2683.60 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 44.28%, FIIs 0.30%, DIIs 0.08%, mutual funds 0.00%.
EquiSense Score (ECS): 79/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.